SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
 - EconoTimes)
NEW YORK, March 06, 2017 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against HMS Holdings Corp. (“HMS” or the “Company”) (Nasdaq:HMSY) in the United States District Court for District of New Jersey on behalf of persons or entities who purchased HMS stock on the open market from May 10, 2016 and March 2, 2017, inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Exchange Act of 1934.
The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) HMS lacked effective internal control over financial reporting; and (2) as a result, HMS’s financial statements were materially false and misleading at all relevant times, and that when the truth was revealed, investors suffered damages.
In November of 2016, HMS revealed that there “could be a material negative impact on our future revenue in future periods” in connection with disputes over the Company’s Medicare Recovery Audit Contractor, owned by HMS, and the Centers for Medicare & Medicaid Services. On this news, HMS shares fell 21.5%, causing tens of millions in losses to investors.
On March 2, 2017, HMS announced it would be unable to timely file its full-year 2016 financial results, revealing that the Company had identified a “material weakness in the Company's internal controls over financial reporting,” resulting in a stock drop of another 2.5%.
If you wish to serve as lead plaintiff, you must move the Court no later than May 2, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.
